Selected article for: "clinical improvement and significant clinical improvement"
Author: Yueping Li; Zhiwei Xie; Weiyin Lin; Weiping Cai; Chunyan Wen; Yujuan Guan; Xiaoneng Mo; Jian Wang; Yaping Wang; Ping Peng; Xudan Chen; Wenxin Hong; Guangming Xiao; Jinxin Liu; Lieguang Zhang; Fengyu Hu; Feng Li; Feng Li; Fuchun Zhang; Xilong Deng; Linghua Li
Title: An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)
  • Document date: 2020_3_23
    • ID: 9hknw4ws_47
    Snippet: During the study period, a total of 13 (15.1%) patients progressed to severe/critical clinical status including 8 receiving LPV/r, 3 receiving arbidol and 2 in the control group, which indicates that disease condition could still worsen even after hospitalization, and thus urgently demands rigorous observation of illness and care. Fortunately, by the endpoint of this study twelve patients had been discharged from hospital after recovery, and only.....
    Document: During the study period, a total of 13 (15.1%) patients progressed to severe/critical clinical status including 8 receiving LPV/r, 3 receiving arbidol and 2 in the control group, which indicates that disease condition could still worsen even after hospitalization, and thus urgently demands rigorous observation of illness and care. Fortunately, by the endpoint of this study twelve patients had been discharged from hospital after recovery, and only one patient remained hospitalized, albeit with significant clinical improvement. This gives us confidence that even in the absence of specific antiviral drugs, the vast majority of COVID-19 patients in severe/critical clinical status can still recover after comprehensive treatment.

    Search related documents:
    Co phrase search for related documents
    • antiviral drug and clinical status: 1, 2, 3
    • antiviral drug and comprehensive treatment: 1, 2, 3, 4
    • antiviral drug and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • antiviral drug and disease condition: 1, 2
    • antiviral drug and hospital discharge: 1, 2, 3, 4
    • antiviral drug and receive arbidol: 1
    • antiviral drug and recovery hospital discharge: 1
    • antiviral drug and significant clinical improvement: 1, 2
    • antiviral drug and specific antiviral drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69
    • antiviral drug and specific antiviral drug absence: 1, 2, 3
    • antiviral drug and study period: 1, 2, 3, 4, 5
    • antiviral drug and vast majority: 1, 2, 3, 4
    • care illness and clinical improvement: 1, 2, 3, 4
    • care illness and clinical status: 1, 2, 3, 4
    • care illness and comprehensive treatment: 1
    • care illness and control group: 1, 2, 3, 4, 5, 6, 7, 8
    • care illness and disease condition: 1, 2, 3, 4, 5
    • care illness and hospital discharge: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • care illness and significant clinical improvement: 1